News of Note—Gritstone Oncology, Inovio Pharmaceuticals and more

Here is some other vaccine news of note for the week:

> Gritstone Oncology lured Actelion CFO Jean-Marc Bellemin for the same role. Release

> A universal flu vaccine candidate from Inovio Pharmaceuticals elicited immune responses against H1N1 strains from the past 100 years in animal models. Release

> Immunovaccine tapped Merck & Co. executive Joseph Sullivan as a senior vice president of business development. Release

> The Wistar Institute won a $1.4 million grant from the Gates Foundation to work on a second-generation malaria vaccine. Release

> Florida lawmakers are weighing a bill that would make HPV vaccination a requirement for public school students. ABC Action News story